MYC and cancer: Similarly, a PROTAC of bromodomain and extraterminal protein 4 (BRD4) for epigenetic regulation of PD-L1 and c-Myc 373 and a carbon-dot-based PROTAC of the PD-L1 protein have been developed for cancer immunotherapy 374.